Close Menu
CryptoHoppers.comCryptoHoppers.com
    What's Hot

    Revolutionizing Ticketing: Formula 1 Embraces NFTs for Luxury Sport | NFT CULTURE | NFT News | Web3 Culture

    May 27, 2023

    Trump taps crypto advocate Stephen Miran as head of his Council of Economic Advisers

    December 23, 2024

    $100,000 Bitcoin Still In Sight, This Analyst Says, But With A Caveat

    August 4, 2023
    Facebook X (Twitter) Instagram
    • Privacy Policy
    • Get In Touch
    Facebook X (Twitter) Instagram
    CryptoHoppers.comCryptoHoppers.com
    • News

      PUMP Whale Exits at $12M Loss: Is a Bounce Finally Coming?

      December 23, 2025

      Grayscale Predicts ‘Rapid’ 1,000x Growth For This Crypto Asset Class By 2030

      December 22, 2025

      Crypto’s Capitol Hill champion Sen. Lummis says she won’t seek re-election

      December 21, 2025

      Load The Bags! Bitcoin MVRV Hits Key Accumulation Threshold

      December 20, 2025

      Korea drives 57M Q2 visits, on-chain retention remains 1-2%

      December 18, 2025
    • Technology

      Shift4 Launches 24/7 Stablecoin Payments on Polygon for Global Merchants

      December 23, 2025

      Blockchain Association Rejects Proposal To Widen Stablecoin Yield Restrictions

      December 22, 2025

      Billions of people still aren’t onboard

      December 21, 2025

      Will Aave Become the Backbone of Global On-Chain Finance by 2026?

      December 20, 2025

      Avalanche foresees a future Built on cistom blockchains

      December 19, 2025
    • Learn/Guide

      Singularity Compute launches first enterprise-grade NVIDIA GPU cluster in Sweden

      December 2, 2025

      First Digital moves toward US listing through merger talks with CSLM SPAC

      December 1, 2025

      Arthur Hayes warns Tether’s Bitcoin and gold bet exposes it to major downside risk

      November 30, 2025

      Arthur Hayes says most L1s outside Ethereum and Solana are headed to zero

      November 29, 2025

      Coinbase Bitcoin premium turns green as US institutions buy again

      November 28, 2025
    • NFTs

      The Unraveling and Rebirth of Digital Ownership: A Post-Mortem on the 2021 NFT Empire and the Rise of Verifiable Utility | NFT CULTURE | NFT News | Web3 Culture

      November 5, 2025

      Triple Trouble: Shepard Fairey, Damien Hirst, and Invader Join Forces for Monumental Exhibition at Newport Street Gallery | NFT CULTURE | NFT News | Web3 Culture

      October 2, 2025

      Slimesunday’s Magnum Opus: ‘Banned from New York’ Blows the Lid Off Digital Censorship | NFT CULTURE | NFT News | Web3 Culture

      July 22, 2025

      1mouth Analog: miirror’s Raw Leap from Digital to Handmade Chaos | NFT CULTURE | NFT News | Web3 Culture

      May 9, 2025

      NFTCulture Expands Into TCGs with Cardcore.xyz: Where Digital Collectibles Meet Competitive Play | NFT CULTURE | NFT News | Web3 Culture

      May 8, 2025
    • Regulation

      Crypto Outlook 2026: Regulation, Institutions, and Technology Shape the Next Market Phase

      December 21, 2025

      Stablecoin Rewards Face Fresh Pushback as Crypto Firms Press Senate Panel

      December 20, 2025

      US Senators Race to Finalize Crypto Market Structure Bill Ahead of Holiday Recess

      December 16, 2025

      Belarus Bars Citizens From Using Foreign Crypto Exchanges

      December 15, 2025

      Capital A & Standard Chartered Explore Malaysia’s First Ringgit-Backed Stablecoin

      December 14, 2025
    • Business

      Uber Commits $2B to Japan in Major Five-Year Expansion Push

      December 16, 2025

      ETF Demand Surpasses New Supply for Ethereum and Bitcoin

      December 15, 2025

      Crypto Giant Tether Attempts Juventus Buyout in Bold Cash Offer

      December 13, 2025

      SBI Digital Markets Partners With Chainlink to Launch Cross-Chain Asset Hub

      November 8, 2025

      UNDP Prepares Global Blockchain Training Initiative for Sustainable Growth

      November 7, 2025
    • Live Pricing
    CryptoHoppers.comCryptoHoppers.com
    Home » 13 Best Healthcare Stocks to Buy in 2025
    News

    13 Best Healthcare Stocks to Buy in 2025

    February 14, 20258 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    13 Best Healthcare Stocks to Buy in 2025
    Share
    Facebook Twitter LinkedIn Pinterest Email



    There have been some major demand-side developments in the healthcare industry in recent years, most notably being driven by an aging global population, growth in the mental health awareness movement, and COVID-19. As a result, healthcare companies with established research and development processes and global supply chains have become a shrewd choice for investors.

    This article lists some of the best healthcare stocks to buy right now, placing a focus on each company’s specialization within the sector and discussing why the stocks could be a great pick.

    The best healthcare stocks to buy in 2025

    1. Lilly(Eli) & Co (LLY) – Leading in diabetes and obesity treatments with a strong pipeline
    2. Johnson & Johnson (JNJ) – Healthcare giant with pharmaceuticals, medical devices, and consumer health products
    3. Pfizer Inc. (PFE) – Known for vaccines and blockbuster drugs, focusing on innovation and expansion
    4. Merck & Co., Inc. (MRK) – Strong oncology and vaccine portfolio, including Keytruda
    5. Abbott Laboratories (ABT) – Specializes in diagnostics, medical devices, and nutrition products
    6. Gilead Sciences, Inc. (GILD) – Leader in antiviral treatments, including HIV and hepatitis drugs
    7. Amgen Inc. (AMGN) – Biotech pioneer focusing on innovative therapies for serious diseases
    8. Biogen Inc. (BIIB) – Focuses on neuroscience, including treatments for Alzheimer’s and multiple sclerosis
    9. Thermo Fisher Scientific Inc. (TMO) – Provides essential tools and services for biotech and pharma research
    10. UnitedHealth Group Incorporated (UNH) – Largest U.S. health insurer with strong healthcare services
    11. Medtronic plc (MDT) – Global leader in medical devices, specializing in cardiovascular and diabetes care
    12. AbbVie Inc (ABBV) – Known for immunology and oncology drugs, including Humira and Rinvoq
    13. Bristol Myers Squibb Company (BMY) – Focuses on oncology, immunology, and cardiovascular treatments

    Ranking the best healthcare companies for investors in 2025

    This section will cover each of the top 13 healthcare stocks to buy, their specializations, and why they represent a good pick in 2025. Let’s dive right in.

    1. Lilly(Eli) & Co (LLY)

    Eli Lilly & Co is a leader in diabetes and obesity treatments, with top-selling drugs like Mounjaro and Trulicity. The company’s strong R&D pipeline extends into oncology, immunology, and neuroscience, positioning it for continued growth. As global healthcare demand rises, LLY remains a strong long-term investment choice.

    Buy Lilly(Eli) & Co Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Lilly(Eli) & Co guide.

    2. Johnson & Johnson (JNJ)

    Johnson & Johnson is a well-established multinational corporation with a strong presence in the healthcare sector. The company is known for its consumer products that span healthcare and cosmetics, and it has built a strong reputation as a trusted brand as a result.

    Additionally, Johnson & Johnson is a leader in pharmaceutical innovation and invests heavily in the research and development of new drugs. JNJ stock provides good dividends, which could help boost investment returns by providing consistent income to shareholders on a quarterly basis.

    Buy Johnson & Johnson Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Johnson & Johnson guide.

    3. Pfizer Inc. (PFE)

    Pfizer pierced public consciousness by developing a globally promoted vaccine for COVID-19, owing to the company’s advanced pharmaceutical research and development processes. A key benefit of buying PFE stock is that the company provides good dividends to shareholders on a quarterly basis.

    Buy Pfizer Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Pfizer guide.

    4. Merck & Co., Inc. (MRK)

    Merck & Co is known for its contributions to medical science and breakthrough therapies, placing a focus on immuno-oncology at the core of its research and development practices. It has a very good reputation in terms of medical ethics and has an extensive portfolio of widely used vaccines for illnesses such as measles, mumps, and rubella.

    Buy Merck & Co Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Merck & Co guide.

    5. Abbott Laboratories (ABT)

    Abbott Laboratories is a diversified healthcare company with a range of products and services. The company operates in diagnostics, medical devices, nutrition, and established pharmaceuticals, and is particularly well known for its development of breakthrough diagnostics technologies.

    Buy Abbott Laboratories Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Abbott Laboratories guide.

    6. Gilead Sciences, Inc. (GILD)

    Gilead Sciences is a biopharmaceutical company known for its focus on developing and commercializing innovative therapies, particularly in the areas of antiviral drugs and liver diseases. Gilead gained attention during the COVID-19 pandemic for its antiviral drug remdesivir, which received Emergency Use Authorization (EUA) for the treatment of the virus.

    Buy Gilead Sciences Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Gilead Sciences guide.

    7. Amgen Inc. (AMGN)

    Amgen is renowned for its innovative work in biotechnology, particularly in the development of biologic drugs. Biologics are often used to treat complex diseases, and Amgen’s industry-leading research and development in the field have given it tremendous value within the global healthcare industry.

    Buy Amgen Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Amgen guide.

    8. Biogen Inc. (BIIB)

    Biogen is a biotechnology company known for its focus on developing therapies for neurological and neurodegenerative diseases. Due to the aging population in western markets, Biogen could represent a shrewd investment over the coming decades as neurodegenerative diseases are particularly common in older demographics.

    Buy Biogen Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Biogen guide.

    9. Thermo Fisher Scientific Inc. (TMO)

    Thermo Fisher Scientific is a leading life sciences company known for its broad range of products and services in the fields of scientific research, healthcare, and diagnostics. The company provided diagnostic tests, laboratory equipment, and other critical supplies to support COVID-19 testing and research, which led to price appreciation for TMO stock.

    Buy Thermo Fisher Scientific Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Thermo Fisher Scientific guide.

    10. UnitedHealth Group Incorporated (UNH)

    UnitedHealth Group is a diversified healthcare company and one of the largest health insurers in the United States. The U.S. healthcare industry operates differently from many other first-world countries, in that healthcare is not supplied as a public good but rather it’s a fully private industry in which insurance plays an important role for affordability. As a result, UnitedHealth looks set to remain an important player in the sector and could be a great investment.

    Buy UnitedHealth Group Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in UnitedHealth Group guide.

    11. Medtronic plc (MDT)

    Medtronic is a global medical technology company that supplies a broad portfolio of medical devices to hospitals and other healthcare centers. Its technological research and development make the company stand out from other options on this list, as Medtronic has positioned itself within an important industry vertical as a well-trusted brand.

    Buy Medtronic Stock

    12. AbbVie Inc (ABBV)

    AbbVie is a pharmaceutical company known for its focus on research and development in various therapeutic areas. The company’s flagship product, Humira, is one of the most popular treatments for rheumatoid arthritis (RA) and has become a best-seller as a result. Additionally, ABBV stocks are known to provide consistently good dividends to shareholders.

    Buy AbbVie Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in AbbVie guide.

    13. Bristol Myers Squibb Company (BMY)

    Bristol Myers Squibb is a global pharmaceutical company with a focus on developing and commercializing innovative medicines. The company is a leader in oncology and has a healthy financial performance, and also invests in schemes to improve patient access and affordability for medical treatments around the world.

    Buy Bristol Myers Squibb Stock

    Your capital is at risk. Other fees may apply. For more information, check out our how to invest in Bristol Myers Squibb guide.

    The bottom line

    As a growing global industry that is in perpetual demand, healthcare stocks can be some of the most secure ways to protect and grow capital over the long term. Each of the companies on our list represents strong picks, but there are other options out there as well. From consumer products, to medical devices and technologies, to the research and development of new medicines, the most influential healthcare companies provide important services for people all over the world, and therefore represent a strong addition to any investment portfolio.

    If you want to invest in other fields as well, such as computing, check out our list of the best semiconductor stocks to buy.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    PUMP Whale Exits at $12M Loss: Is a Bounce Finally Coming?

    December 23, 2025

    Grayscale Predicts ‘Rapid’ 1,000x Growth For This Crypto Asset Class By 2030

    December 22, 2025

    Crypto’s Capitol Hill champion Sen. Lummis says she won’t seek re-election

    December 21, 2025

    Load The Bags! Bitcoin MVRV Hits Key Accumulation Threshold

    December 20, 2025
    Top Posts

    Ethereum’s Vitalik Buterin Becomes Proud Parent of Meme-Famous Hippo Moo Deng

    December 27, 2024

    Gemini to Inject $24M in India to Enhance Its Infrastructure Development Plan at Gurgaon

    September 27, 2023

    MOLLARS presale ongoing, project building a decentralized store of value ecosystem

    December 20, 2023

    Welcome to CryptoHoppers.com! Stay informed with the latest updates, trends, and insights from the dynamic world of cryptocurrencies. From Bitcoin to altcoins, blockchain technology to decentralized finance (DeFi), we cover it all. Discover expert analysis, market trends, regulatory developments, and exciting innovations shaping the crypto industry.

    Top Insights

    PUMP Whale Exits at $12M Loss: Is a Bounce Finally Coming?

    December 23, 2025

    Grayscale Predicts ‘Rapid’ 1,000x Growth For This Crypto Asset Class By 2030

    December 22, 2025

    Crypto’s Capitol Hill champion Sen. Lummis says she won’t seek re-election

    December 21, 2025
    Advertisement
    Demo
    CryptoHoppers.com
    Facebook X (Twitter) Instagram
    • News
    • Technology
    • Learn/Guide
    • Regulation
    • NFTs
    • Business
    • Live Pricing
    © 2025. Designed by CryptoHoppers.com.

    Type above and press Enter to search. Press Esc to cancel.